SubHero Banner
Text

Jynneos (smallpox and monkeypox vaccine, live, nonreplicating) – New drug approval

September 24, 2019 - The FDA announced the approval of Bavarian Nordic’s Jynneos (smallpox and monkeypox vaccine, live, nonreplicating), for prevention of smallpox and monkeypox disease in adults18 years of age and older determined to be at high risk for smallpox or monkeypox infection.

Download PDF